Foot-and-mouth disease virus (FMDV) is a highly contagious virus that infects cloven-hoofed animals.
Neutralizing antibodies play critical roles in
antiviral infection. Although five known
antigen sites that induce
neutralizing antibodies have been defined, studies on cross-protective
antigen sites are still scarce. We mapped two cross-protective
antigen sites using 13 bovine-derived broadly neutralizing
monoclonal antibodies (
bnAbs) capable of neutralizing 4 lineages within 3 topotypes of FMDV serotype O. One
antigen site was formed by a novel cluster of VP3-focused
epitopes recognized by
bnAb C4 and C4-like
antibodies. The cryo-electron microscopy (cryo-EM) structure of the FMDV-OTi (O/Tibet/99)-C4 complex showed close contact with VP3 and a novel interprotomer
antigen epitope around the icosahedral 3-fold axis of the FMDV particle, which is far beyond the known
antigen site 4. The key determinants of the neutralizing function of C4 and C4-like
antibodies on the capsid were βB (T65), the B-C loop (T68), the E-F loop (E131 and K134), and the H-I loop (G196), revealing a novel
antigen site on VP3. The other
antigen site comprised two group
epitopes on VP2 recognized by 9
bnAbs (B57, B73, B77, B82, F28, F145, F150, E46, and E54), which belong to the known
antigen site 2 of FMDV serotype O. Notably,
bnAb C4 potently promoted FMDV
RNA release in response to damage to viral particles, suggesting that the targeted
epitope contains a trigger mechanism for particle disassembly. This study revealed two cross-protective
antigen sites that can elicit cross-reactive
neutralizing antibodies in cattle and provided new structural information for the design of a broad-spectrum
molecular vaccine against FMDV serotype O. IMPORTANCE FMDV is the causative agent of
foot-and-mouth disease (FMD), which is one of the most contagious and economically devastating diseases of domestic animals. The antigenic structure of FMDV serotype O is rather complicated, especially for those sites that can elicit a cross-protective
neutralizing antibody response. Monoclonal neutralization
antibodies provide both crucial defense components against FMDV
infection and valuable tools for fine analysis of the antigenic structure. In this study, we found a cluster of novel VP3-focused
epitopes using 13
bnAbs against FMDV serotype O from natural host cattle, which revealed two cross-protective
antigen sites on VP2 and VP3. Antibody C4 targeting this novel
epitope potently promoted viral particle disassembly and
RNA release before
infection, which may indicate a vulnerable region of FMDV. This study reveals new structural information about cross-protective
antigen sites of FMDV serotype O, providing valuable and strong support for future research on broad-spectrum
vaccines against FMD.